Generac CEO reports 5,000-share sale at $167.42 under 10b5-1 plan
Rhea-AI Filing Summary
Aaron Jagdfeld, who serves as Chief Executive Officer and a Director of Generac Holdings Inc. (GNRC), reported a sale of 5,000 shares of the issuer's common stock on 10/01/2025 at a price of $167.42 per share. After the reported transaction, the filing shows he beneficially owns 547,966 shares directly. The Form 4 notes that the transaction was made under a previously adopted 10b5-1(c) trading plan with an adoption date of 03/06/2025. The form was signed on 10/02/2025 by an attorney-in-fact.
Positive
- 10b5-1(c) plan adoption dated 03/06/2025 provides pre-scheduled trading framework
- Full disclosure of sale date, price, and post-transaction holdings enhances transparency
Negative
- Disposition of 5,000 shares on 10/01/2025 at $167.42 reduced direct holdings
- Form 4 filed by attorney-in-fact rather than the reporting person (signed 10/02/2025)
Insights
Insider sale executed under a pre-existing 10b5-1 plan, reducing holdings modestly.
The Form 4 shows a reported sale of 5,000 shares on 10/01/2025 at $167.42 per share, with a post-transaction direct beneficial ownership of 547,966 shares. The filing explicitly states the 10b5-1(c) plan adoption date as 03/06/2025, indicating the trade was planned rather than ad hoc.
This matters for governance because trades under a 10b5-1 plan are typically pre-scheduled, which helps limit questions about trading on nonpublic information; the filing provides the specific adoption date and transaction detail required for transparency.
Reported sale size is small relative to total reported holdings; limited market impact.
The reported disposition of 5,000 shares represents less than 1% of the reported 547,966 shares held directly after the sale, according to the Form 4 figures. The filing contains the exact sale price ($167.42) and transaction date (10/01/2025), allowing precise record of insider activity.
Because the Form 4 discloses both the trade and the 10b5-1 plan adoption date (03/06/2025), market participants can treat this as a scheduled insider sale with minimal information asymmetry; no other derivative or additional transactions are reported.